Loading clinical trials...
Loading clinical trials...
An Investigation of Tumor Genomics, Individual Risk Factors, and External Drivers of Health to Improve Health Outcomes for Patients With Meningioma
Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.
PRIMARY OBJECTIVES: I. To assess prevalence and distribution of social and structural determinants of health (SSDH) among meningioma patients. II. To assess disparities in SSDH among meningioma patients of different races. OUTLINE: This is an observational study. Participants will complete a survey and have their medical records reviewed.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
University of California San Francisco
San Francisco, California, United States
Start Date
April 30, 2026
Primary Completion Date
January 1, 2031
Completion Date
January 1, 2032
Last Updated
February 18, 2026
3,000
ESTIMATED participants
Questionnaire
BEHAVIORAL
Medical Record Review
OTHER
Lead Sponsor
University of California, San Francisco
Collaborators
NCT05839379
NCT06962215
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05940493